| Pharmaceuticals Industry | Healthcare Sector | Mr. Hee-Deok Park CEO | KRX SM Exchange | KR7004720009 ISIN |
| KR Country | 226 Employees | - Last Dividend | 24 Jul 2012 Last Split | - IPO Date |
PharmGen Science, Inc. is a prominent pharmaceutical company based in South Korea that focuses on the research, development, production, and sale of a broad range of pharmaceutical products. Originally established in 1957 as Wooridul Pharmaceutical Limited, the company underwent a significant rebranding to become PharmGen Science, Inc. It is situated in Hwaseong-si, South Korea, indicating its strategic location for both domestic and potential international market reach. The company's long history and evolution speak to its resilience and adaptability in the dynamic pharmaceutical industry.
PharmGen Science, Inc. offers an extensive portfolio of products and services that cater to various health needs, emphasizing its commitment to improving health outcomes and enhancing quality of life. The company's offerings include: